211 related articles for article (PubMed ID: 34272692)
1. Multienzyme Kinetics and Sequential Metabolism.
Wienkers LC; Rock BM
Methods Mol Biol; 2021; 2342():89-112. PubMed ID: 34272692
[TBL] [Abstract][Full Text] [Related]
2. Multienzyme kinetics and sequential metabolism.
Wienkers LC; Rock B
Methods Mol Biol; 2014; 1113():93-118. PubMed ID: 24523110
[TBL] [Abstract][Full Text] [Related]
3. Enzyme Kinetics of Oxidative Metabolism-Cytochromes P450.
Korzekwa K
Methods Mol Biol; 2021; 2342():237-256. PubMed ID: 34272697
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
[TBL] [Abstract][Full Text] [Related]
5. Explaining the atypical reaction profiles of heme enzymes with a novel mechanistic hypothesis and kinetic treatment.
Manoj KM; Baburaj A; Ephraim B; Pappachan F; Maviliparambathu PP; Vijayan UK; Narayanan SV; Periasamy K; George EA; Mathew LT
PLoS One; 2010 May; 5(5):e10601. PubMed ID: 20498847
[TBL] [Abstract][Full Text] [Related]
6. Enzyme kinetics of oxidative metabolism: cytochromes P450.
Korzekwa K
Methods Mol Biol; 2014; 1113():149-66. PubMed ID: 24523112
[TBL] [Abstract][Full Text] [Related]
7. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
Narasimhulu S
Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Manikandan P; Nagini S
Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
[TBL] [Abstract][Full Text] [Related]
9. Development of new Coumarin-based profluorescent substrates for human cytochrome P450 enzymes.
Juvonen RO; Ahinko M; Huuskonen J; Raunio H; Pentikäinen OT
Xenobiotica; 2019 Sep; 49(9):1015-1024. PubMed ID: 30272491
[TBL] [Abstract][Full Text] [Related]
10. Versatile biocatalysis of fungal cytochrome P450 monooxygenases.
Durairaj P; Hur JS; Yun H
Microb Cell Fact; 2016 Jul; 15(1):125. PubMed ID: 27431996
[TBL] [Abstract][Full Text] [Related]
11. Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research.
Zhao L; Sun N; Tian L; Zhao S; Sun B; Sun Y; Zhao D
Bioorg Med Chem Lett; 2019 Aug; 29(16):2016-2024. PubMed ID: 31257085
[TBL] [Abstract][Full Text] [Related]
12. Monooxygenase, peroxidase and peroxygenase properties and reaction mechanisms of cytochrome P450 enzymes.
Hrycay EG; Bandiera SM
Adv Exp Med Biol; 2015; 851():1-61. PubMed ID: 26002730
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
He K; Woolf TF; Hollenberg PF
J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590
[TBL] [Abstract][Full Text] [Related]
14. From electrochemistry to enzyme kinetics of cytochrome P450.
Shumyantseva VV; Kuzikov AV; Masamrekh RA; Bulko TV; Archakov AI
Biosens Bioelectron; 2018 Dec; 121():192-204. PubMed ID: 30218927
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.
Yadav J; Paragas E; Korzekwa K; Nagar S
Pharmacol Ther; 2020 Feb; 206():107449. PubMed ID: 31836452
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450-activated prodrugs: targeted drug delivery.
Huttunen KM; Mähönen N; Raunio H; Rautio J
Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
[TBL] [Abstract][Full Text] [Related]
17. Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.
VandenBranden M; Ring BJ; Binkley SN; Wrighton SA
Pharmacogenetics; 1996 Feb; 6(1):81-91. PubMed ID: 8845864
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the 1.85 A structure of CYP154A1 from Streptomyces coelicolor A3(2) with the closely related CYP154C1 and CYPs from antibiotic biosynthetic pathways.
Podust LM; Bach H; Kim Y; Lamb DC; Arase M; Sherman DH; Kelly SL; Waterman MR
Protein Sci; 2004 Jan; 13(1):255-68. PubMed ID: 14691240
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
20. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
Guengerich FP; Wilkey CJ; Phan TTN
J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
